This company cannot, will not, and more importantly doesn't want to change. Novartis didnt buy us for the BM business; it was for the lab. It was cheaper and faster for them to buy us then to create a CLEA approved lab for their "companion diagnostics". If only a handful of patients in a DSC's territory get switched from Gleevac to Tasigna, Novartis makes more money then all the BM that DSC could possibky bring in.
Guys please wake up, the gravy train is over. You are being held accountable for business that our parent company couldn't care less about. That's why we are losing our edge in the market place.
DSCs are obsolete now; they aren't even backfilling our positions, hell they didn't even backfill the Northeast RD spot. Think about that, we are probably the ONLY national lab that doesn't have an RD for the NY//NJ metro area. How is the same guy running Iowa going to be able to help NY.
Instead of laying us all off, they're going to make life tough so people leave or get fired. That will cut down on severence severely.
In the end ask yourself....Are you happy here? Do you want to work for downsizing organization? Do you want to fight hard for your clients only to be bludgeoned with lackluster corporate solutions or our "legal team" handcuffing you at every turn?
The grass is most definitely greener, simply because at Genoptix no ones watering the lawn anymore.
